Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 3
2011 3
2012 8
2013 16
2014 21
2015 30
2016 19
2017 12
2018 17
2019 12
2020 2
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
Qu Y, Middleton MS, Loomba R, Glaser KJ, Chen J, Hooker JC, Wolfson T, Covarrubias Y, Valasek MA, Fowler KJ, Zhang YN, Sy E, Gamst AC, Wang K, Mamidipalli A, Schwimmer JB, Song B, Reeder SB, Yin M, Ehman RL, Sirlin CB. Qu Y, et al. Eur Radiol. 2021 Nov;31(11):8408-8419. doi: 10.1007/s00330-021-07988-6. Epub 2021 Apr 26. Eur Radiol. 2021. PMID: 33899143 Free PMC article.
Treatment Candidacy for Pharmacologic Therapies for NASH.
Rowe IA, Wong VW, Loomba R. Rowe IA, et al. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1209-1217. doi: 10.1016/j.cgh.2021.03.005. Epub 2021 Mar 10. Clin Gastroenterol Hepatol. 2022. PMID: 33711479 Free PMC article. Review.
Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
Caussy C, Brissot J, Singh S, Bassirian S, Hernandez C, Bettencourt R, Rizo E, Richards L, Sirlin CB, Loomba R. Caussy C, et al. Clin Gastroenterol Hepatol. 2020 Jul;18(8):1842-1850.e6. doi: 10.1016/j.cgh.2019.11.060. Epub 2019 Dec 13. Clin Gastroenterol Hepatol. 2020. PMID: 31843596 Free PMC article.
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.
Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, Jones MB, Sirlin CB, Schnabl B, Brinkac L, Schork N, Chen CH, Brenner DA, Biggs W, Yooseph S, Venter JC, Nelson KE. Loomba R, et al. Cell Metab. 2019 Sep 3;30(3):607. doi: 10.1016/j.cmet.2019.08.002. Cell Metab. 2019. PMID: 31484056 Free PMC article. No abstract available.
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.
Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, Bettencourt R, Rizo E, Richards L, Xu ZZ, Downes MR, Evans RM, Brenner DA, Sirlin CB, Knight R, Loomba R. Caussy C, et al. Nat Commun. 2019 Mar 29;10(1):1406. doi: 10.1038/s41467-019-09455-9. Nat Commun. 2019. PMID: 30926798 Free PMC article.
Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography.
Caussy C, Bhargava M, Villesen IF, Gudmann NS, Leeming DJ, Karsdal MA, Faulkner C, Bao D, Liu A, Lo MT, Bettencourt R, Bassirian S, Richards L, Brenner DA, Chen CH, Sirlin CB, Loomba R. Caussy C, et al. Hepatology. 2019 Jul;70(1):127-141. doi: 10.1002/hep.30610. Epub 2019 Apr 29. Hepatology. 2019. PMID: 30859582 Free PMC article.
116 results